Hvsen Biotechnology Co., Ltd.
SZSE:300871.SZ
14.16 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,019.759 | 1,022.901 | 996.217 | 777.459 | 427.217 | 421.874 | 399.716 | 257.783 |
| Cost of Revenue
| 806.466 | 797.537 | 725.496 | 489.589 | 263.549 | 238.147 | 197.016 | 122.002 |
| Gross Profit
| 213.293 | 225.363 | 270.721 | 287.87 | 163.668 | 183.727 | 202.7 | 135.781 |
| Gross Profit Ratio
| 0.209 | 0.22 | 0.272 | 0.37 | 0.383 | 0.436 | 0.507 | 0.527 |
| Reseach & Development Expenses
| 44.598 | 40.138 | 46.888 | 28.382 | 21.109 | 20.356 | 17.952 | 12.793 |
| General & Administrative Expenses
| 10.544 | 11.092 | 17.328 | 13.706 | -25.167 | -24.465 | -19.967 | 15.386 |
| Selling & Marketing Expenses
| 55.628 | 48.428 | 47.154 | 52.556 | 38.821 | 46.742 | 57.86 | 49.242 |
| SG&A
| 66.172 | 59.52 | 64.482 | 66.262 | 13.653 | 22.277 | 37.893 | 64.628 |
| Other Expenses
| -2.641 | -2.447 | -0.195 | -0.485 | 3.065 | 2.434 | 0.148 | 3.671 |
| Operating Expenses
| 171.359 | 146.038 | 134.531 | 109.849 | 80.362 | 88.245 | 97.219 | 80.059 |
| Operating Income
| 15.083 | 59.157 | 151.028 | 176.517 | 78.555 | 81.49 | 103.38 | 54.517 |
| Operating Income Ratio
| 0.015 | 0.058 | 0.152 | 0.227 | 0.184 | 0.193 | 0.259 | 0.211 |
| Total Other Income Expenses Net
| -2.641 | -2.447 | -0.195 | -0.485 | 0.046 | 0.178 | 0.344 | 3.671 |
| Income Before Tax
| 12.442 | 56.71 | 150.832 | 176.032 | 78.602 | 81.668 | 103.724 | 58.188 |
| Income Before Tax Ratio
| 0.012 | 0.055 | 0.151 | 0.226 | 0.184 | 0.194 | 0.259 | 0.226 |
| Income Tax Expense
| -4.339 | 4.003 | 17.967 | 25.876 | 9.836 | 10.266 | 15.314 | 8.79 |
| Net Income
| 16.781 | 52.706 | 132.866 | 150.156 | 68.766 | 71.402 | 88.424 | 49.423 |
| Net Income Ratio
| 0.016 | 0.052 | 0.133 | 0.193 | 0.161 | 0.169 | 0.221 | 0.192 |
| EPS
| 0.1 | 0.32 | 0.8 | 0.91 | 0.41 | 0.59 | 0.74 | 0.41 |
| EPS Diluted
| 0.1 | 0.32 | 0.8 | 0.91 | 0.41 | 0.59 | 0.74 | 0.41 |
| EBITDA
| 176.6 | 149.275 | 174.647 | 203.01 | 103.597 | 112.015 | 117.331 | 63.893 |
| EBITDA Ratio
| 0.173 | 0.146 | 0.175 | 0.261 | 0.242 | 0.266 | 0.294 | 0.248 |